Crown Advisors Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Crown Advisors Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,000	Closed	-$1.04M	–	44
2024 Q3	$1.04M	Hold	15,000	–	–	0.67%	38
2024 Q2	$1.01M	Hold	15,000	–	–	0.65%	38
2024 Q1	$1.03M	Hold	15,000	–	–	0.63%	39
2023 Q4	$933K	Hold	15,000	–	–	0.64%	41
2023 Q3	$841K	Hold	15,000	–	–	0.6%	42
2023 Q2	$757K	Hold	15,000	–	–	0.49%	48
2023 Q1	$818K	Buy	15,000 +5,000	+50%	+$292K	0.61%	43
2022 Q4	$625K	Hold	10,000	–	–	0.57%	42
2022 Q3	$704K	Hold	10,000	–	–	0.7%	38
2022 Q2	$566K	Buy	+10,000	New	+$548K	0.52%	43
2020 Q1	–	Sell	-100,000	Closed	-$2.77M	–	53
2019 Q4	$2.77M	Buy	+100,000	New	+$2.39M	1.78%	29

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crown Advisors Management's AXNX Position: Q4 2024 in Review

Crown Advisors Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 15,000 shares — an estimated $1.04M sold.

Crown Advisors Management first reported a position in AXNX in Q4 2019 and held it in 11 quarters. The position peaked at $2.77M in Q4 2019. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Crown Advisors Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Crown Advisors Management sold 15,000 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.04M.
Crown Advisors Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Crown Advisors Management's Axonics, Inc. Common Stock position peaked at $2.77M in Q4 2019.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Crown Advisors Management's 13F filing for Q4 2024, filed 11 Feb 2025.